<strong>Higher aspirin dose may reduce prostate cancer mortality</strong>

Irish researchers have found that men who take above 75 mg of aspirin had a 39 percent decreased risk of death from prostate cancer when compared to men not taking aspirin. Researchers at the University of Dublin studied 2,936 men with localized prostate cancer; 1,131 of them were aspirin users. A low-dose aspirin is considered 75 mg.